A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates
Adeno-associated virus (AAV) has provided the gene therapy field with the most powerful in vivo gene delivery vector to realize safe, efficacious, and sustainable therapeutic gene expression. Because many clinically relevant properties of AAV-based vectors are governed by the capsid, much research e...
Main Authors: | Dan Wang, Shaoyong Li, Dominic J. Gessler, Jun Xie, Li Zhong, Jia Li, Karen Tran, Kim Van Vliet, Lingzhi Ren, Qin Su, Ran He, Jason E. Goetzmann, Terence R. Flotte, Mavis Agbandje-McKenna, Guangping Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050118300330 |
Similar Items
-
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
by: Nicholas M. Kanaan, et al.
Published: (2017-09-01) -
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features
by: Mario Mietzsch, et al.
Published: (2021-01-01) -
Mapping the AAV capsid host antibody response towards the development of second generation gene delivery vectors
by: Yu-Shan eTseng, et al.
Published: (2014-01-01) -
Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
by: Yong Zi Tan, et al.
Published: (2018-09-01) -
Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
by: George V Aslanidi, et al.
Published: (2013-01-01)